Comorbidity Between Depressive and Addictive Disorders in Adolescents
52. Breese GR, Chu K, Dayas CV, et al., Stress enhancement of craving during sobriety: a risk for relapse, Alcohol Clin Exp Res, 2005;29:185–95.
53. Cleck JN, Blendy JA, Making a bad thing worse: adverse effects of stress on drug addiction, J Clin Invest, 2008;118:454–61.
54. Barrett AE, Turner RJ, Family structure and substance use problems in adolescence and early adulthood: examining explanations for the relationship, Addiction, 2006;101:109–20.
55. Clark DB, Lesnick L, Hegedus AM, Traumas and other adverse life events in adolescents with alcohol abuse and
dependence, J Am Acad Child Adolesc Psychiatry, 1997;36:1744–51.
56. Dube SR, Felitti VJ, Dong M, et al., Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study, Pediatrics, 2003;111:564–72.
57. Fishbein DH, Herman-Stahl M, Eldreth D, et al., Mediators of the stress-substance-use relationship in urban male
adolescents, Prev Sci, 2006;7:113–26.
58. Lloyd DA, Turner RJ, Cumulative lifetime adversities and alcohol dependence in adolescence and young adulthood,
Drug Alcohol Depend, 2008;93:217–26.
59. Newcomb MD, Harlow LL, Life events and substance use among adolescents: mediating effects of perceived loss of control and meaninglessness in life, J Pers Soc Psychol, 1986;51:564–77.
60. Sher KJ, Gershuny BS, Peterson L, et al., The role of childhood stressors in the intergenerational transmission of alcohol use disorders, J Stud Alcohol, 1997;58:414–27.
61. Turner RJ, Lloyd DA, Cumulative adversity and drug dependence in young adults: racial/ethnic contrasts,
62. Windle M, Wiesner M, Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes,
Dev Psychopathol, 2004;16:1007–27.
63. Dunn MG, Tarter RE, Mezzich AC, et al., Origins and consequences of child neglect in substance abuse families,
Clin Psychol Rev, 2002;22:1063–90.
64. Brown SA, Stetson BA, Beatty PA, Cognitive and behavioral features of adolescent coping in high-risk drinking
situations, Addict Behav, 1989;14:43–52.
65. Kuntsche E, Knibbe R, Gmel G, et al., Why do young people drink? A review of drinking motives, Clin Psychol Rev, 2005;25:841–61.
66. Litman GK, Stapleton J, Oppenheim AN, et al., The relationship between coping behaviours, their effectiveness and alcoholism relapse and survival, Br J Addict, 1984;79:283–91.
67. Measelle JR, Stice E, Springer DW, A prospective test of the negative affect model of substance abuse: moderating effects of social support, Psychol Addict Behav, 2006;20:225–33.
68. Peirce RS, Frone MR, Russell M, et al., A longitudinal model of social contact, social support, depression, and alcohol
use, Health Psychol, 2000;19:28–38.
69. Wills TA, Cleary SD, Stress-coping model for alcohol/tobacco interactions in adolescence. In: Fertig J, Allen J (eds), Alcohol
and tobacco: from basic science to policy, Bethesda, MD:
Department of Health and Human Services, National Institute on Alcohol Abuse and Alcoholism, 1995;107–128.
70. Wills TA, Cleary SD, How are social support effects mediated? A test with parental support and adolescent
substance use, J Pers Soc Psychol, 1996;71:937–52.
71. Sher KJ, Levenson RW, Risk for alcoholism and individual differences in the stress-response-dampening effect of
alcohol, J Abnorm Psychol, 1982;91:350–67.
72. Cloninger CR, A systematic method for clinical description and classification of personality variants. A proposal, Arch
Gen Psychiatry, 1987;44:573–88.
73. Saraceno L, Munafo M, Heron J, et al., Genetic and non- genetic influences on the development of co-occurring alcohol problem use and internalizing symptomatology in adolescence: a review, Addiction, 2009;104:1100–21.
74. Kendler KS, Prescott CA, Myers J, et al., The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and
women, Arch Gen Psychiatry, 2003;60:929–37.
75. Rao U, Hammen CL, London ED, et al., Contribution of hypothalamic-pituitary-adrenal activity and environmental stress to vulnerability for smoking in adolescents,
76. Rao U, Hammen CL, Poland RE, Mechanisms underlying the comorbidity between depressive and addictive disorders in adolescents: interactions between stress and HPA activity,
Am J Psychiatry, 2009;166:361–9.
77. Sher KJ, Walitzer KS, Wood PK, et al., Characteristics of children of alcoholics: putative risk factors, substance use and abuse, and psychopathology, J Abnorm Psychol, 1991;100:427–48.
78. Peirce RS, Frone MR, Russell M, et al., Relationship of financial strain and psychosocial resources to alcohol use and abuse: the mediating role of negative affect and
drinking motives, J Health Soc Behav, 1994;35:291–308.
79. Rao U, Ryan ND, Dahl RE, et al., Factors associated with the development of substance use disorder in depressed
adolescents, J Am Acad Child Adolesc Psychiatry, 1999;38:1109–17.
80. De Kloet ER, Hormones and the stressed brain, Ann N Y Acad
81. Lopez JF, Akil H, Watson SJ, Neural circuits mediating stress,
Biol Psychiatry, 1999;46:1461–71.
82. McEwen BS, Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders,
Ann N Y Acad Sci, 2004;1032:1–7.
83. Sullivan RM, Gratton A, Prefrontal cortical regulation of hypothalamic-pituitary-adrenal function in the rat and implications for psychopathology: side matters,
84. Gillespie CF, Phifer J, Bradley B, et al., Risk and resilience: genetic and environmental influences on development of the stress response, Depress Anxiety, 2009;26:984–92.
85. Bartels M, Van den Berg M, Sluyter F, et al., Heritability of cortisol levels: review and simultaneous analysis of twin studies, Psychoneuroendocrinology, 2003;28:121–37.
86. Federenko IS, Nagamine M, Hellhammer DH, et al., The heritability of hypothalamus-pituitary-adrenal axis responses to psychosocial stress is context dependent, J Clin Endocrinol
87. Holsboer F, Stress, Hypercortisolism and corticosteroid receptors in depression: implications for therapy, J Affect
88. Burke HM, Davis MC, Otte C, et al., Depression and cortisol responses to psychological stress: a meta-analysis,
89. Lopez-Duran NL, Kovacs M, George CJ, Hypothalamic- pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis, Psychoneuroendocrinology, 2009;34:1272–83.
90. Heim C, Plotsky PM, Nemeroff CB, Importance of studying the contributions of early adverse experience to neurobiological findings in depression, Neuropsychopharmacology, 2004;29:641–8.
91. Kaufman J, Charney D, Effects of early stress on brain structure and function: implications for understanding the relationship between child maltreatment and depression,
Dev Psychopathol, 2001;13:451–71.
92. Bradley RG, Binder EB, Epstein MP, et al., Influence of child abuse on adult depression: moderation by the corticotropin- releasing hormone receptor gene, Arch Gen Psychiatry, 2008;65:190–200.
93. Caspi A, Sugden K, Moffitt TE, et al., Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene, Science, 2003;301:386–9.
94. Kaufman J, Yang BZ, Douglas-Palumberi H, et al., Social supports and serotonin transporter gene moderate
depression in maltreated children, Proc Natl Acad Sci U S A,
95. Barrot M, Marinelli M, Abrous DN, et al., The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens
is hormone-dependent, Eur J Neurosci, 2000;12:973–9.
96. Funk CK, O’Dell LE, Crawford EF, et al., Corticotropin- releasing factor within the central nucleus of the amygdala
mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats, J Neurosci, 2006;26:11324–32.
97. Goeders NE, Bienvenu OJ, De Souza EB, Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain, Brain Res, 1990;531:322–8.
98. Stewart J, Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking, J Psychiatry
99. Bruijnzeel AW, Repetto M, Gold MS, Neurobiological mechanisms in addictive and psychiatric disorders,
Psychiatr Clin North Am, 2004;27:661–74.
100.Piazza PV, Le Moal M, The role of stress in drug self-
administration, Trends Pharmacol Sci, 1998;19:67–74.
101.Thatcher-Britton K, Koob GF, Alcohol reverses the proconflict effect of corticotropin-releasing factor,
Regul Pept, 1986;16:315–20.
102.Rivier C, Imaki T, Vale W, Prolonged exposure to alcohol: effect on CRF mRNA levels, and CRF- and stress-induced ACTH secretion in the rat, Brain Res, 1990;520:1–5.
103.Goeders NE, A neuroendocrine role in cocaine reinforcement, Psychoneuroendocrinology, 1997;22:237–59.
104.Waltman C, Blevins LS, Jr, Boyd G, et al., The effects of mild ethanol intoxication on the hypothalamic-pituitary-adrenal axis
in nonalcoholic men, J Clin Endocrinol Metab, 1993;77:518–22.
105.Zobel AW, Schulze-Rauschenbach S, von Widdern OC, et al., Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant
treatment, J Psychiatr Res, 2004;38:377–83.
106.Moss HB, Vanyukov M, Yao JK, et al., Salivary cortisol responses in prepubertal boys: the effects of parental substance abuse and association with drug use behavior during adolescence, Biol Psychiatry, 1999;45:1293–9.
107.Clark DB, Parker AM, Lynch KG, Psychopathology and substance-related problems during early adolescence:
a survival analysis, J Clin Child Psychol, 1999;28:333–41.
108.Fu Q, Heath AC, Bucholz KK, et al., Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder
in men, Arch Gen Psychiatry, 2002;59:1125–32.
109.Fahlke C, Hard E, Thomasson R, et al., Metyrapone-induced suppression of corticosterone synthesis reduces ethanol consumption in high-preferring rats, Pharmacol Biochem Behav, 1994;48:977–81.
110.Heinrichs SC, Menzaghi F, Schulteis G, et al., Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal, Behav
111.Piazza PV, Marinelli M, Jodogne C, et al., Inhibition of corticosterone synthesis by Metyrapone decreases cocaine- induced locomotion and relapse of cocaine self-
administration, Brain Res, 1994;658:259–64.
112.Rassnick S, Heinrichs SC, Britton KT, et al., Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal, Brain Res, 1993;605:25–32.
113.Gallagher P, Malik N, Newham J, et al., Antiglucocorticoid
treatments for mood disorders, Cochrane Database Syst Rev,
114.Holsboer F, Ising M, Central CRH system in depression and anxiety—evidence from clinical studies with CRH1 receptor
antagonists, Eur J Pharmacol, 2008;583:350–57.
115.Nunes EV, Sullivan MA, Levin FR, Treatment of depression in patients with opiate dependence, Biol Psychiatry, 2004;56: 793–802.
116.Torrens M, Fonseca F, Mateu G, et al., Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and
meta-analysis, Drug Alcohol Depend, 2005;78:1–22.
117.Duman RS, Malberg J, Thome J, Neural plasticity to stress and antidepressant treatment, Biol Psychiatry, 1999;46:1181–91.
118.Manber R, Kraemer HC, Arnow BA, et al., Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone, J Consult Clin
| Page 2
| Page 3
| Page 4
| Page 5
| Page 6
| Page 7
| Page 8
| Page 9
| Page 10
| Page 11
| Page 12
| Page 13
| Page 14
| Page 15
| Page 16
| Page 17
| Page 18
| Page 19
| Page 20
| Page 21
| Page 22
| Page 23
| Page 24
| Page 25
| Page 26
| Page 27
| Page 28
| Page 29
| Page 30
| Page 31
| Page 32
| Page 33
| Page 34
| Page 35
| Page 36
| Page 37
| Page 38
| Page 39
| Page 40
| Page 41
| Page 42
| Page 43
| Page 44
| Page 45
| Page 46
| Page 47
| Page 48
| Page 49
| Page 50
| Page 51
| Page 52
| Page 53
| Page 54
| Page 55
| Page 56
| Page 57
| Page 58
| Page 59
| Page 60
| Page 61
| Page 62
| Page 63
| Page 64
| Page 65
| Page 66
| Page 67
| Page 68